APNT Nanoparticle Formulation Platform

Model: APNT

Exhibitor: FORMOSA PHARMACEUTICALS , INC

Booth No: M520

Characteristic

√ APNT® is Formosa Pharma’s proprietary formulation platform developed to enhance the dissolution and bioavailability of poorly soluble drugs by reducing particle size to the nanoscale.
√ Unlike traditional milling methods, APNT® technology does not use metal or plastic beads, thereby eliminating the risk of contamination from bead debris.
√ Instead, it employs high-purity salts and sugars as milling media, which are safe and can be integrated into the final formulation.
√ The APNT® platform is highly versatile, suitable for oral dosage forms, dry powder inhalers (DPIs), nebulized respiratory therapies, topical dermatological treatments, and ophthalmic drug delivery.
√ The platform’s druggability has been validated by the U.S. FDA approval of APP13007 in 2024—a novel ophathalmic drug derived from APNT® technology.
√ APNT® nanoparticle formulations have also been demonstrated to work effectively with mesh-type nebulizers, allowing for efficient inhalation delivery.

Other Products

Products you may be interested in

Highest Rated Products

Back

Menu

APNT Nanoparticle Formulation Platform

Characteristic

Other Products

Products you may be interested in

Highest Rated Products